DOI QR코드

DOI QR Code

Psychiatric Symptoms after Taking Oseltamivir in a Child and Its Causality Assessment

Oseltamivir 복용 이후 소아에서 발생한 이상행동 및 그 인과성 평가

  • 손병우 (가천대학교 약학대학) ;
  • 최중혁 (가천대학교 약학대학) ;
  • 이승민 (가천대학교 약학대학) ;
  • 박선순 (인천광역시약사회 의약품식품안전센터) ;
  • 최은경 (인천광역시약사회 의약품식품안전센터) ;
  • 유봉규 (가천대학교 약학대학) ;
  • 지은희 (가천대학교 약학대학)
  • Received : 2018.12.05
  • Accepted : 2019.01.28
  • Published : 2019.03.31

Abstract

Oseltamivir is an antiviral medication prescribed to prevent and treat influenza A and B. A case from a community pharmacy in Korea was reported for an adverse event associated with oseltamivir administration. A 20-month-old boy had psychiatric symptoms after receiving 2 doses of oseltamivir. Therefore, an evaluation of whether the psychiatric symptoms were caused by oseltamivir was required. To determine whether the adverse event resulted from the administrated medication or other factors, three tools were used: the Naranjo scale, the Korean causality assessment algorithm (Ver.2), and the World Health Organization-Uppsala Monitoring Center (WHO-UMC) criteria. The psychiatric symptoms occurred after oseltamivir administration, and were attenuated after oseltamivir termination. A possible cause of the psychiatric symptoms is high fever, but information on the body temperature of the patient was not sufficient. Therefore, it was unclear whether there were other nonpharmacological causes of adverse drug reaction. For these reasons, in terms of causality, the results evaluated by the three tools represented, "possible", "probable", and "probable/likely", respectively.

Keywords

References

  1. Korea Centers for Disease Control and Prevention (KCDC). Infectious Disease Portal. Available from http://www.cdc.go.kr/npt/biz/npp/portal/nppSumryMain.do?icdCd=C0022&icdgrpCd=03&icdSubgrpCd=. Accessed November 22, 2018.
  2. Chosun. "I got the flu even though I got vaccinated"...WHO's missed prediction. Available from http://news.chosun.com/site/data/html_dir/2018/01/17/2018011701363.html. Accessed November 22, 2018.
  3. Centers for Disease Control and Prevention (CDC). Influenza (Flu). Available from https://www.cdc.gov/flu. Accessed November 22, 2018.
  4. Korean Index of Medical Specialties (KIMS). Ingredient information. Available from http://www.kimsonline.co.kr/drugcenter/generic/geninfo. Accessed November 22, 2018.
  5. Dailypharm. An epidemic of influenza; transition to generic competition..."Hanmiflu smiled". Available from http://www.dailypharm.com/Users/News/NewsView.html?ID=237846&dpsearch=%C7%D1%B9%CC%C7%C3%B7%E7. Accessed November 22, 2018.
  6. Dailypharm. 'The evolutionary generic medications as game changers' pushing out the original medications. Available from http://www.dailypharm.com/Users/News/NewsView.html?ID=240749&dpsearch=%C7%D1%B9%CC%C7%C3%B7%E7. Accessed November 22, 2018.
  7. Health Sciences Authority (HSA). Adverse Drug Reaction news. Available form https://www.hsa.gov.sg/content/dam/HSA/HPRG/Safety_Alerts_Product_Recalls_Enforcement/Adverse_Drug_Reaction_News/2006/ADR_News_Dec2006_Vol8_No3.pdf. Accessed November 22, 2018.
  8. Dalvi PS, Singh A, Trivedi HR, Mistry SD, Vyas BR. Adverse drug reaction profile of oseltamivir in children. J Pharmacol Pharmacother 2011;2(2):100-3. https://doi.org/10.4103/0976-500X.81901
  9. Hama R. Fatal neuropsychiatric adverse reactions to osletamivir: Case series and overview of causal relationships. Int J Risk Saf Med 2008;20(2008):5-36. https://doi.org/10.3233/JRS-2008-0431
  10. Tsz-Yin So and Suresh N. Oseltamivir and Neuropsychiatric Behaviors - A Case Report on an Adolescent Teen and Evaluation of the Literature. Pediatric Sciences 2009;1(6):1-6.
  11. Leentjens AF, Schieveld JN, Leonard M, Lousberg R, Verhey FR, Meagher DJ. A comparison of the phenomenology of pediatric, adult, and geriatric delirium. J Psychosom Res 2008;64(2):219-23 https://doi.org/10.1016/j.jpsychores.2007.11.003
  12. Sogabe K, Lee T, Sou M, Miyasaka K. Safety and efficacy of midazolam in children under mechanical ventilation in the intensive care unit. Masui 2012;61(11):1245-60.
  13. University of Virginia School of Medicine. Department of Periatrics. Available from https://med.virginia.edu/pediatrics/wp-content/uploads/sites/237/2015/12/199503.pdf. Accessed November 23, 2018.
  14. Mayo Clinic School of Continuous Professional Development. Available from https://ce.mayo.edu/sites/ce.mayo.edu/files/PediatricDelirium%2010252016Steinauerslides.pdf. Accessed November 22, 2018.
  15. Jeon SW and Han C. Psychiatric Symptoms in a Patient with Influenza A (H1N1) Treated with Oseltamivir (Tamiflu): A Case Report. Clin Psychopharmacol Neurosci 2015;13(2):209-11. https://doi.org/10.9758/cpn.2015.13.2.209
  16. Ono H, Okamura M, Fukushima A. Similarity of Clinically Significant Neuropsychiatric Adverse Reactions Listed in Package Inserts between the Anti-influenza Drugs Oseltamivir and Amantadine (Possibility Attributable to Common Pharmacological Effects). Yakugaku Zasshi 2018;138(9):1201-15. https://doi.org/10.1248/yakushi.18-00022
  17. Lee H, Jo YJ, Yoon JS, Ji E. Hyperprolactinemia after taking Levosulpiride and its Casuality Assessment: An Adverse Event Reported by a Community Pharmacy. Korean J Clin Pharm 2018;28(2):154-7. https://doi.org/10.24304/kjcp.2018.28.2.154

Cited by

  1. Fluctuations in influenza-like illness epidemics and suicide mortality: A time-series regression of 13-year mortality data in South Korea vol.16, pp.2, 2021, https://doi.org/10.1371/journal.pone.0244596